2024-03-28T12:57:32Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_FE88A92B1E23
2024-03-23T03:15:59Z
serval:BIB_FE88A92B1E23
Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics.
10.1128/AAC.44.7.1789-1795.2000
000087961400004
10858332
Vouillamoz
J.
author
Entenza
J.M.
author
Féger
C.
author
Glauser
M.P.
author
Moreillon
P.
author
article
2000
Antimicrobial Agents and Chemotherapy
0066-4804
0066-4804
journal
44
7
1789-1795
Animals
Anti-Bacterial Agents/blood
Anti-Bacterial Agents/pharmacology
Cefamandole/blood
Cefamandole/therapeutic use
Cephalosporins/blood
Cephalosporins/therapeutic use
Disease Models, Animal
Drug Resistance, Microbial
Drug Resistance, Multiple
Drug Therapy, Combination/blood
Drug Therapy, Combination/therapeutic use
Endocarditis, Bacterial/drug therapy
Endocarditis, Bacterial/metabolism
Humans
Lincosamides
Macrolides
Microbial Sensitivity Tests
Rats
Staphylococcal Infections/drug therapy
Staphylococcal Infections/metabolism
Staphylococcus aureus/drug effects
Time Factors
Virginiamycin/blood
Virginiamycin/pharmacology
eng
60_published
true